Matthew Yglesias @mattyglesias
If India (or whichever other country) has some solution to that logistical problem that would allow for more doses of the Pfizer or Moderna vaccine to be manufactured, then it seems like there should be a straightforward licensing deal. If they don’t, the patents won’t help. — PolitiTweet.org